IMB:LSEImperial Brands PLC Analysis
Data as of 2026-03-10 - not real-time
£3,144.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
The stock trades at 3,144 p, roughly 10% below the DCF‑derived fair value of 4,239 p, indicating a material upside. Its forward PE of 8.35 and current PE of 12.6 place it on the cheap side of the tobacco peer set, while a 5.1% dividend yield and a 75% payout ratio deliver attractive income. Profitability is robust, with a 38.7% ROE and a 19.8% operating margin, and free cash flow of £2.5 bn comfortably covers the high debt‑to‑equity ratio of 189%. The 30‑day volatility of 24% suggests price swings, but a beta near zero (0.1) shows minimal market‑wide correlation. Technicals show the 20‑day SMA (3,241 p) still above price, hinting at short‑term pressure, yet the 200‑day SMA (3,075 p) remains well below, confirming a longer‑term bullish backdrop.
Momentum indicators are mixed – the MACD histogram is negative and the signal line is bearish, while the RSI sits at a neutral 44 and the price hovers just above the identified support at 3,124 p. The market sentiment index reads “Extreme Greed” (77), implying investor optimism that could accelerate a move toward the resistance zone near 3,340 p. Given the strong cash generation, generous dividend, and undervaluation, the stock appears positioned for a rebound, though regulatory scrutiny of the tobacco sector remains a headwind. Investors should weigh the upside potential against the high leverage and the modest growth outlook (4.6% revenue growth). Overall, the profile suggests a compelling entry point for income‑focused investors with a tolerance for sector‑specific risk.
Momentum indicators are mixed – the MACD histogram is negative and the signal line is bearish, while the RSI sits at a neutral 44 and the price hovers just above the identified support at 3,124 p. The market sentiment index reads “Extreme Greed” (77), implying investor optimism that could accelerate a move toward the resistance zone near 3,340 p. Given the strong cash generation, generous dividend, and undervaluation, the stock appears positioned for a rebound, though regulatory scrutiny of the tobacco sector remains a headwind. Investors should weigh the upside potential against the high leverage and the modest growth outlook (4.6% revenue growth). Overall, the profile suggests a compelling entry point for income‑focused investors with a tolerance for sector‑specific risk.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- price near support at 3,124 p
- bearish MACD indicates short‑term downside risk
- attractive dividend yield of 5.1%
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- undervaluation relative to DCF fair value
- strong cash flow covering high leverage
- regulatory headwinds may limit price appreciation
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- high ROE and consistent cash generation
- sustainable dividend payout
- defensive consumer sector with long‑term demand
Key Metrics & Analysis
Financial Health
Revenue Growth4.60%
Profit Margin10.91%
P/E Ratio12.6
ROE38.74%
ROA7.73%
Debt/Equity189.01
P/B Ratio524.2
Op. Cash Flow£3.6B
Free Cash Flow£2.5B
Technical Analysis
TrendBullish
RSI43.7
Support£3,124.00
Resistance£3,340.00
MA 20£3,241.25
MA 50£3,149.86
MA 200£3,074.84
MACDBearish
VolumeDecreasing
Fear & Greed Index77.32
Valuation
Fair Value£4,238.50
Target Price£3,465.39
Upside/Downside10.22%
GradeUndervalued
TypeBlend
Dividend Yield5.10%
Risk Assessment
Beta-0.04
Volatility24.34%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.